PCAR
43
3
VNO
57
5
CB
31
-2
XYL
45
-7
BRK.B
40
-2
CMS
61
-6
BEN
29
4
QRVO
9
-2
BAC
69
4
BDX
44
-2
CMA
73
2
ILMN
11
2
BIIB
40
-2
FLS
67
2
MA
65
-2
KIM
48
-6
USB
61
6
NWL
8
2
F
48
6
CF
41
2
PCAR
43
3
VNO
57
5
CB
31
-2
XYL
45
-7
BRK.B
40
-2
CMS
61
-6
BEN
29
4
QRVO
9
-2
BAC
69
4
BDX
44
-2
CMA
73
2
ILMN
11
2
BIIB
40
-2
FLS
67
2
MA
65
-2
KIM
48
-6
USB
61
6
NWL
8
2
F
48
6
CF
41
2
Financhill
Back

East Japan Railway Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
74

EJPRY
East Japan Railway

Last Price:
$9.25
Seasonality Move:
-1.22%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.31
Seasonality Move:
1.75%
Buy
74
East Japan Railway (EJPRY) is a Buy

Is East Japan Railway a Buy, Sell or Hold?

  • The current East Japan Railway [EJPRY] share price is $9.07. The Score for EJPRY is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • EJPRY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EJPRY Stock Price Chart

What is East Japan Railway's stock price today?

  • The East Japan Railway share price today is $9.07
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EJPRY is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

EJPRY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 59.39 Buy
Chaikin Money Flow: -45030 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.53 - 8.95) Buy
Bollinger Bands (100): (8.77 - 9.85) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

EJPRY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.94 Buy
20-day SMA: 8.8 Buy
50-day SMA: 8.88 Buy
200-day SMA: 9.14 Sell
8-day EMA: 8.95 Buy
20-day EMA: 8.86 Buy
50-day EMA: 8.93 Buy
200-day EMA: 9.18 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

East Japan Railway Earnings Growth & EJPRY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

East Japan Railway Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):